EMAMI LIMITED (EMAMILTD) financials
EMAMI LIMITED (EMAMILTD) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
- Market Cap: ₹16,419Cr.
- Current Price: ₹376
- Stock P/E: 18.9
- ROE: 26.6%
- ROCE: 28.4%
- Book Value: ₹72.3
- Dividend Yield: 2.66%
- 52W High / Low: ₹556/361
In Jun 2026, EMAMI LIMITED (EMAMILTD) reported sales ₹780 Cr and net profit ₹182 Cr.
Annual TTM: sales ₹3,072 Cr, net profit ₹861 Cr.
Shareholding: Promoters 54.84% (Sep 2026), FIIs 9.02% (Sep 2026), DIIs 23.57% (Sep 2026), Public 12.57% (Sep 2026), No. of Shareholders 1,31,538% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 709 | 879 | 781 | 756 | 604 | 958 | 730 | 780 |
| Expenses | 483 | 550 | 590 | 556 | 437 | 572 | 533 | 564 |
| Operating Profit | 226 | 328 | 191 | 201 | 168 | 385 | 196 | 215 |
| OPM % | 32% | 37% | 24% | 27% | 28% | 40% | 27% | 28% |
| Other Income | 34 | 10 | 66 | 21 | 54 | 9 | 25 | 53 |
| Interest | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 40 | 40 | 39 | 39 | 40 | 40 | 36 | 34 |
| Profit before tax | 221 | 298 | 217 | 182 | 181 | 354 | 185 | 234 |
| Tax % | 3% | 6% | 13% | 10% | -1% | 7% | 10% | 22% |
| Net Profit | 214 | 279 | 190 | 163 | 182 | 330 | 166 | 182 |
| EPS in Rs | 4.90 | 6.40 | 4.35 | 3.74 | 4.18 | 7.56 | 3.81 | 4.17 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,390 | 2,582 | 2,867 | 2,907 | 2,922 | 3,124 | 3,048 | 3,072 |
| Expenses | 1,798 | 1,738 | 1,970 | 2,129 | 2,070 | 2,186 | 2,098 | 2,107 |
| Operating Profit | 592 | 845 | 897 | 777 | 852 | 937 | 950 | 965 |
| OPM % | 25% | 33% | 31% | 27% | 29% | 30% | 31% | 31% |
| Other Income | 91 | 103 | 123 | 48 | 63 | 157 | 108 | 141 |
| Interest | 19 | 12 | 3 | 4 | 2 | 2 | 2 | 2 |
| Depreciation | 326 | 361 | 328 | 215 | 167 | 158 | 156 | 150 |
| Profit before tax | 338 | 574 | 689 | 606 | 747 | 934 | 901 | 953 |
| Tax % | 14% | 17% | -23% | 5% | 7% | 8% | 7% | — |
| Net Profit | 289 | 475 | 851 | 574 | 693 | 859 | 842 | 861 |
| EPS in Rs | 6.37 | 10.69 | 19.28 | 13.00 | 15.89 | 19.68 | 19.28 | 19.72 |
| Dividend Payout % | 63% | 75% | 41% | 62% | 50% | 51% | 52% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 45 | 45 | 44 | 44 | 44 | 44 | 44 | 44 |
| Reserves | 2,019 | 1,757 | 1,715 | 2,042 | 2,220 | 2,339 | 2,824 | 3,112 |
| Borrowings | 54 | 158 | 47 | 224 | 21 | 22 | 14 | 92 |
| Other Liabilities | 464 | 475 | 498 | 516 | 467 | 441 | 503 | 478 |
| Total Liabilities | 2,583 | 2,435 | 2,304 | 2,826 | 2,751 | 2,847 | 3,384 | 3,726 |
| Fixed Assets | 1,643 | 1,422 | 1,100 | 1,270 | 1,088 | 960 | 840 | 748 |
| CWIP | 36 | 8 | 6 | 3 | 2 | 5 | 12 | 1 |
| Investments | 187 | 161 | 264 | 361 | 392 | 560 | 995 | 1,196 |
| Other Assets | 716 | 844 | 934 | 1,192 | 1,270 | 1,322 | 1,536 | 1,780 |
| Total Assets | 2,583 | 2,435 | 2,304 | 2,826 | 2,751 | 2,847 | 3,384 | 3,726 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 513 | 546 | 878 | 596 | 731 | 740 | 864 | 794 |
| Cash from Investing Activity | 20 | -251 | -200 | -188 | -106 | -192 | -465 | -257 |
| Cash from Financing Activity | -434 | -399 | -679 | -398 | -612 | -546 | -368 | -462 |
| Net Cash Flow | 99 | -105 | -0 | 10 | 13 | 1 | 31 | 75 |
| Free Cash Flow | 384 | 403 | 847 | 122 | 710 | 713 | 824 | 760 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 85% | 103% | 112% | 81% | 108% | 102% | 110% | 99% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% |
| FIIs | 14.11% | 12.11% | 11.89% | 10.93% | 9.03% | 8.57% | 7.87% | 9.02% |
| DIIs | 21.70% | 23.68% | 24.06% | 25.00% | 26.72% | 26.91% | 27.00% | 23.57% |
| Public | 9.36% | 9.38% | 9.21% | 9.22% | 9.40% | 9.67% | 10.28% | 12.57% |
| No. of Shareholders | 1,28,725 | 1,29,002 | 1,26,599 | 1,26,776 | 1,29,077 | 1,27,615 | 1,31,617 | 1,31,538 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 28 | 14 | 25 | 33 | 35 | 33 | 23 |
| Inventory Days | 89 | 102 | 116 | 123 | 102 | 102 | 97 | 135 |
| Days Payable | 94 | 108 | 120 | 111 | 88 | 91 | 103 | 118 |
| Cash Conversion Cycle | 16 | 22 | 10 | 37 | 47 | 46 | 27 | 39 |
| Working Capital Days | 12 | 12 | 2 | 8 | 42 | 42 | 37 | 32 |
| ROCE % | 19% | 17% | 30% | 31% | 26% | 31% | 34% | 28% |
Emami Limited
₹16,419Cr.
₹376
₹556/361
18.9
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of EMAMI LIMITED (EMAMILTD)?
The reported market capitalisation for EMAMI LIMITED (EMAMILTD) is ₹16,419Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of EMAMILTD?
The current price shown for EMAMI LIMITED (EMAMILTD) on Fincrux is ₹376 with a 52-week high/low of ₹556/361.
What is the P/E ratio of EMAMI LIMITED (EMAMILTD)?
The stock P/E for EMAMI LIMITED (EMAMILTD) is 18.9 on Fincrux, with ROE at 26.6% and ROCE at 28.4%.
What were EMAMILTD latest quarterly results?
For Jun 2026, EMAMI LIMITED (EMAMILTD) reported sales ₹780 Cr and net profit ₹182 Cr (figures in ₹ crore unless noted).
What are EMAMILTD annual sales and net profit?
For TTM, EMAMI LIMITED (EMAMILTD) shows sales of ₹3,072 Cr and net profit of ₹861 Cr on the Fincrux profit & loss statement.
Who owns EMAMI LIMITED (EMAMILTD)?
Latest shareholding for EMAMI LIMITED (EMAMILTD) on Fincrux: Promoters 54.84% (Sep 2026), FIIs 9.02% (Sep 2026), DIIs 23.57% (Sep 2026), Public 12.57% (Sep 2026), No. of Shareholders 1,31,538% (Sep 2026).
Where can I find EMAMI LIMITED (EMAMILTD) financials?
EMAMI LIMITED (EMAMILTD) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show EMAMILTD balance sheet and cash flow?
Yes. The EMAMI LIMITED (EMAMILTD) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.